Items where authors include "Latham, S."
Article
Abani, O., Abbas, A., Abbas, F. et al. (8021 more authors) (2025) Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. eClinicalMedicine, 81. 103080. ISSN 2589-5370
Dark, P., Hossain, A., McAuley, D.F. et al. (543 more authors) (2025) Biomarker-guided antibiotic duration for hospitalized patients with suspected sepsis: the ADAPT-sepsis randomized clinical trial. Journal of the American Medical Association (JAMA), 333 (8). pp. 682-693. ISSN 0098-7484
Parajuli, A., Mitchell, J., King, N. orcid.org/0000-0002-4215-2323 et al. (4 more authors) (2024) Drivers of antimicrobial resistance within the communities of Nepal from One Health perspective: a scoping review. Frontiers in Public Health, 12. 1384779. ISSN 2296-2565
Faust, S.N., Haynes, R., Jones, C.E. et al. (7370 more authors) (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child & Adolescent Health, 8 (3). pp. 190-200. ISSN 2352-4642
Sandercock, P., Darbyshire, J., DeMets, D. et al. (2050 more authors) (2024) Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Nature Communications, 15. 924. ISSN 2041-1723
Parajuli, A., Garbovan, L., Bhattarai, B. et al. (7 more authors) (2024) Exploring community insights on antimicrobial resistance in Nepal: a formative qualitative study. BMC Health Services Research, 24 (1). 57. ISSN 1472-6963
Mitchell, J., Arjyal, A., Baral, S. et al. (11 more authors) (2023) Co-designing community-based interventions to tackle antimicrobial resistance (AMR): what to include and why. BMC Research Notes, 16 (1). 290. ISSN 1756-0500
Abani, O., Abbas, A., Abbas, F. et al. (7989 more authors) (2023) Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Diabetes & Endocrinology, 11 (12). pp. 905-914. ISSN 2213-8587
Mitchell, J. orcid.org/0000-0002-2892-4630, Hawkings, H., Latham, S. et al. (11 more authors) (2023) Addressing antimicrobial resistance through community engagement: a framework for developing contextually relevant and impactful behaviour change interventions. JAC-Antimicrobial Resistance, 5 (6). ARTN dlad124. ISSN 2632-1823
Lurati Buse, G.A., Mauermann, E., Ionescu, D. et al. (245 more authors) (2023) Risk assessment for major adverse cardiovascular events after noncardiac surgery using self-reported functional capacity: international prospective cohort study. British Journal of Anaesthesia, 130 (6). pp. 655-665. ISSN 0007-0912
Abani, O., Abbas, A., Abbas, F. et al. (8104 more authors) (2023) Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 401 (10387). pp. 1499-1507. ISSN 0140-6736
Kousathanas, A. orcid.org/0000-0001-6265-6521, Pairo-Castineira, E. orcid.org/0000-0002-2423-3090, Rawlik, K. orcid.org/0000-0002-0010-370X et al. (2377 more authors) (2022) Whole-genome sequencing reveals host factors underlying critical COVID-19. Nature, 607. pp. 97-103. ISSN 0028-0836